ST Pharm Co.,Ltd. Statistics

Total Valuation

ST Pharm Co.,Ltd. has a market cap or net worth of KRW 2.19 trillion. The enterprise value is 2.24 trillion.

Market Cap	2.19T
Enterprise Value	2.24T

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

ST Pharm Co.,Ltd. has 20.09 million shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding	20.09M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	+1.63%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	12.26%
Float	12.32M

Valuation Ratios

The trailing PE ratio is 94.51 and the forward PE ratio is 46.65. ST Pharm Co.,Ltd.'s PEG ratio is 0.77.

PE Ratio	94.51
Forward PE	46.65
PS Ratio	7.52
PB Ratio	4.96
P/FCF Ratio	n/a
PEG Ratio	0.77

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.72, with an EV/FCF ratio of -96.92.

EV / Earnings	103.01
EV / Sales	8.19
EV / EBITDA	43.72
EV / EBIT	82.76
EV / FCF	-96.92

Financial Position

The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.37.

Current Ratio	4.25
Quick Ratio	2.03
Debt / Equity	0.37
Debt / EBITDA	3.12
Debt / FCF	-6.92
Interest Coverage	4.42

Financial Efficiency

Return on equity (ROE) is 5.14% and return on invested capital (ROIC) is 3.15%.

Return on Equity (ROE)	5.14%
Return on Assets (ROA)	2.76%
Return on Capital (ROIC)	3.15%
Revenue Per Employee	410.36M
Profits Per Employee	32.64M
Employee Count	665
Asset Turnover	0.45
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+42.22%
50-Day Moving Average	100,388.00
200-Day Moving Average	85,016.50
Relative Strength Index (RSI)	56.11
Average Volume (20 Days)	473,470

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ST Pharm Co.,Ltd. had revenue of KRW 272.89 billion and earned 21.71 billion in profits. Earnings per share was 1,151.15.

Revenue	272.89B
Gross Profit	96.43B
Operating Income	27.02B
Pretax Income	26.89B
Net Income	21.71B
EBITDA	51.14B
EBIT	27.02B
Earnings Per Share (EPS)	1,151.15

Full Income Statement

Balance Sheet

The company has 110.31 billion in cash and 159.54 billion in debt, giving a net cash position of -49.23 billion or -2,451.21 per share.

Cash & Cash Equivalents	110.31B
Total Debt	159.54B
Net Cash	-49.23B
Net Cash Per Share	-2,451.21
Equity (Book Value)	428.24B
Book Value Per Share	21,934.82
Working Capital	248.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.47 billion and capital expenditures -45.54 billion, giving a free cash flow of -23.07 billion.

Operating Cash Flow	22.47B
Capital Expenditures	-45.54B
Free Cash Flow	-23.07B
FCF Per Share	-1,148.48

Full Cash Flow Statement

Margins

Gross margin is 35.34%, with operating and profit margins of 9.90% and 7.95%.

Gross Margin	35.34%
Operating Margin	9.90%
Pretax Margin	9.85%
Profit Margin	7.95%
EBITDA Margin	18.74%
EBIT Margin	9.90%
FCF Margin	-8.45%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.46%.

Dividend Per Share	500.00
Dividend Yield	0.46%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	43.33%
Buyback Yield	-0.24%
Shareholder Yield	0.22%
Earnings Yield	1.06%
FCF Yield	-1.06%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ST Pharm Co.,Ltd. has an Altman Z-Score of 4.91.

Altman Z-Score	4.91
Piotroski F-Score	n/a